Navigation Links
Laureate Pharma Honored as Emerging Life Sciences Company of the Year

PRINCETON, N.J., Nov. 20 /PRNewswire/ -- Laureate Pharma, Inc., a full-service biopharmaceutical development and protein production company, today announced that it has been named the "Emerging Life Science Company of the Year" by The Eastern Technology Council, the largest technology and life sciences trade association in the greater Philadelphia, PA region. The company was honored for its innovation in services, achievement of milestones and strength of its management team, at the ETC's annual Enterprise Awards Gala at Philadelphia's Kimmel Center on November 18th.

(Logo: )

Laureate is an established leader in the contract manufacture of clinical supply of biopharmaceutical products that target diseases including various types of cancer, autoimmune diseases, bone disorders and infectious diseases. Over the past few years Laureate has demonstrated strong growth, expanding its facility and manufacturing capacity as well as capabilities. Laureate has achieved several milestones during its impressive history, including commissioning a new pilot plant, and becoming EBITDA positive in 2007. In addition, the company has signed major biopharmaceutical development and manufacturing contracts and fill/finish agreements growing its market share and boosting its revenue.

"We are honored to receive this prestigious Enterprise award from Eastern Technology Council," said Robert Broeze, Ph.D., President and the Chief Executive Officer of Laureate Pharma. "This is a tribute to our leadership, and our talented and committed staff. It is a great recognition of our world-class operations and our strategy for business success. The award validates our commitment to the advancement in human health and our vision of partnering with our clients to improve the quality of all the lives we touch."

The Enterprise Awards is the Eastern Technology Council's annual celebration of regional life sciences and technology companies and their leaders. The Emerging Life Science Company Award honors a company that has at least four years of strong operating results and revenues less than $50 million. Key considerations for the award include product or service innovation, strategic decisions that led to growth in revenues and/or earnings, and demonstrated ability to raise capital and achieve profitability.

About Laureate Pharma, Inc.

Laureate Pharma is a full-service biopharmaceutical development and protein production company located in Princeton, New Jersey. Laureate Pharma offers superior bioprocessing services that accelerate new products from development through production. Laureate provides a wide range of specialized services from process design and development to full-scale cGMP production, purification, aseptic filling, testing, validation, analytical services, and regulatory support. Laureate is focused on two active segments of the biopharmaceutical industry: monoclonal antibodies and recombinant protein products. For more information, contact Michael Cavanaugh, Vice President Sales, Marketing, and Business Development at (609) 919-3400, or or visit

SOURCE Laureate Pharma, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Laureate Pharma Announces Agreement with Tolera Therapeutics, Inc.
2. Laureate Announces Manufacturing Agreement with Tolerx
3. Laureate Pharma to Add More Manufacturing Capacity
4. ARUP Laboratories ARUP Consult(R) Recognized as a Computerworld Honors Program Laureate
5. Laureate Pharma Announces Manufacturing Agreement With Alopexx Pharmaceuticals, LLC
6. Laureate Pharma Reports Record Growth for 2007
7. Laureate Pharma Appoints Gary Swan as Vice President of Operations
8. Laureate Announces Manufacturing Agreement with ARIUS for Trop-2 Targeting Antibody
9. ARIUS announces manufacturing Agreement with Laureate Pharma For Trop-2 targeting antibody
10. American Scientists Named as Laureates of the 2008 (24th) Japan Prize
11. Thomson Scientific Salutes Nobel Laureate Prize Winners, Many of Whom Were Selected as Thomson Scientific Laureates in 2006
Post Your Comments:
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... compared the implantation and pregnancy rates in frozen and fresh in vitro ... of progesterone and maternal age to IVF success. , After comparing the results ...
(Date:10/10/2017)... ... October 10, 2017 , ... San Diego-based team building and cooking events ... announced today. The bold new look is part of a transformation to increase ... a significant growth period. , It will also expand its service offering from its ...
(Date:10/10/2017)... ... October 10, 2017 , ... For ... has won a US2020 STEM Mentoring Award. Representatives of the FirstHand program travelled ... Volunteer Experience from US2020. , US2020’s mission is to change the trajectory of ...
(Date:10/10/2017)... , Oct. 10, 2017 International research firm Parks ... Strategy, will speak at the TMA 2017 Annual Meeting , October ... trends in the residential home security market and how smart safety and ... Parks ... "The residential ...
Breaking Biology Technology:
(Date:4/13/2017)... According to a new market research report "Consumer ... Administration, and Authorization), Service, Authentication Type, Deployment Mode, Vertical, and Region - ... to grow from USD 14.30 Billion in 2017 to USD 31.75 Billion ... ... MarketsandMarkets Logo ...
(Date:4/6/2017)... , April 6, 2017 Forecasts ... ANPR, Document Readers, by End-Use (Transportation & Logistics, Government ... Oil, Gas & Fossil Generation Facility, Nuclear Power), Industrial, ... Other) Are you looking for a definitive ... ...
(Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
Breaking Biology News(10 mins):